At the recent annual meeting of the American Association for Clinical Chemistry, Siemens Healthineers featured its Atellica Solution for the first time since the system received FDA premarket notification (510(k)) clearance. The Atellica Solution combines clinical chemistry and immunoassay analyzers with sample management components to form a scalable system suited for both mid- and high-volume diagnostic laboratories.

Delivering flexibility to adapt to growing testing needs and space constraints, the Atellica Solution can combine up to 10 components into more than 300 customizable configurations—including linear, L, and U shapes.

“Siemens Healthineers is driving healthcare forward in the digital age by delivering fast and easy interaction between data and knowledge, to go along with our complete in vivo and in vitro offerings,” says Michael Reitermann, chief operating officer at Siemens Healthineers.

At AACC, Siemens Healthineers also showcased Atellica Diagnostics IT. The family of products includes connectivity management, data management, inventory management, process management, and clinical decision support for multisite laboratories seeking real-time analytics to improve workflow and efficiency. Atellica Diagnostics IT features customizable parameters, performance-monitoring capabilities, and centralized control over day-to-day laboratory operations to improve business and clinical outcomes.

Franz Walt, MBA, Siemens Healthineers.

Franz Walt, MBA, Siemens Healthineers.

“FDA clearance for the Atellica Solution opens the door for us to change the game in laboratory diagnostics with a revolutionary platform designed by customers for customers,” says Franz Walt, president of laboratory diagnostics at Siemens Healthineers. “Combined with the Atellica Solution, our highly integrated Atellica Diagnostics IT will simplify lab workflows to meet increasing testing demand.”

For more information, visit Siemens Healthineers.